- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Global Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
75
High return on equity, past performance and sound balance sheet.
75 companies
Anthem Biosciences
Market Cap: ₹402.9b
Operates as technology-focused contract research, development, and manufacturing organization.
ANTHEM
₹717.35
7D
-0.06%
1Y
n/a
Basilea Pharmaceutica
Market Cap: CHF 568.3m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 46.25
7D
-5.1%
1Y
8.1%
Neuren Pharmaceuticals
Market Cap: AU$2.8b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$21.94
7D
4.8%
1Y
77.7%
Abbott India
Market Cap: ₹629.7b
Operates as a pharmaceutical company in India.
500488
₹29,635.15
7D
-1.5%
1Y
2.3%
ChemoMetec
Market Cap: DKK 13.8b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 792.00
7D
13.6%
1Y
98.0%
Medpace Holdings
Market Cap: US$16.5b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$580.37
7D
-2.7%
1Y
84.7%
SK Biopharmaceuticals
Market Cap: ₩8.9t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩113,400.00
7D
6.7%
1Y
-3.8%
GlaxoSmithKline Pakistan
Market Cap: PK₨125.5b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨393.97
7D
-5.7%
1Y
51.7%
Torrent Pharmaceuticals
Market Cap: ₹1.2t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹3,600.90
7D
-0.5%
1Y
12.5%
Jamjoom Pharmaceuticals Factory
Market Cap: ر.س10.8b
Engages in the manufacture and distribution of pharmaceutical and consumer products in the Kingdom of Saudi Arabia, Gulf, Iraq, Egypt, North Africa, and internationally.
4015
ر.س156.00
7D
2.1%
1Y
-7.7%
Blue Jet Healthcare
Market Cap: ₹112.3b
Engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products.
BLUEJET
₹647.35
7D
-0.6%
1Y
36.9%
Henan Lingrui Pharmaceutical
Market Cap: CN¥12.6b
Produces and sells medicines in China.
600285
CN¥22.32
7D
-3.0%
1Y
4.1%
Jiang Zhong PharmaceuticalLtd
Market Cap: CN¥13.4b
Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China.
600750
CN¥21.37
7D
-2.0%
1Y
1.5%
Consun Pharmaceutical Group
Market Cap: HK$12.7b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$15.05
7D
0.5%
1Y
82.0%
Exelixis
Market Cap: US$10.6b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$38.94
7D
2.3%
1Y
17.3%
Waters
Market Cap: US$20.4b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$342.90
7D
-3.6%
1Y
6.1%
Lotus Pharmaceutical
Market Cap: NT$75.9b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$288.50
7D
1.4%
1Y
14.7%
Middle East Pharmaceutical Industries
Market Cap: ر.س2.7b
Engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.
4016
ر.س137.20
7D
0.3%
1Y
2.5%
BioArctic
Market Cap: SEK 25.7b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 290.00
7D
-0.5%
1Y
97.4%
Catalyst Pharmaceuticals
Market Cap: US$2.6b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$20.97
7D
1.2%
1Y
-3.8%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥47.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China.
688578
CN¥105.38
7D
0.4%
1Y
102.8%
DHG Pharmaceutical
Market Cap: ₫13.8t
Engages in the manufacture and sale of pharmaceutical products in Vietnam.
DHG
₫105,600.00
7D
0.3%
1Y
1.0%
ACADIA Pharmaceuticals
Market Cap: US$3.8b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD
US$22.74
7D
4.6%
1Y
55.9%
Harmony Biosciences Holdings
Market Cap: US$1.7b
A commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States.
HRMY
US$28.90
7D
-2.4%
1Y
-10.1%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.8b
Engages in the pharmaceutical business in China.
000915
CN¥33.39
7D
1.7%
1Y
16.8%
argenx
Market Cap: €43.0b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€702.40
7D
-0.3%
1Y
29.7%
Incyte
Market Cap: US$17.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$92.59
7D
3.7%
1Y
24.9%
WuXi AppTec
Market Cap: CN¥288.7b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥97.06
7D
-4.7%
1Y
86.7%
Lupin
Market Cap: ₹888.4b
Operates as a pharmaceutical company in India, the United States, and internationally.
500257
₹1,945.10
7D
0.3%
1Y
-11.0%
Genmab
Market Cap: DKK 113.2b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,839.50
7D
-5.1%
1Y
19.9%
Gubra
Market Cap: DKK 6.8b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 414.80
7D
-2.1%
1Y
-3.5%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥27.7b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥42.17
7D
-2.3%
1Y
27.5%
HBM Holdings
Market Cap: HK$11.1b
A biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally.
2142
HK$13.21
7D
6.5%
1Y
991.7%
NATCO Pharma
Market Cap: ₹149.3b
A pharmaceutical company, engages in the research and development, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹833.30
7D
-0.1%
1Y
-40.6%
CytomX Therapeutics
Market Cap: US$537.6m
Operates as an oncology-focused biopharmaceutical company that focuses on developing novel conditionally activated biologics localized to the tumor microenvironment.
CTMX
US$3.33
7D
0.9%
1Y
234.4%
Zealand Pharma
Market Cap: DKK 33.2b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 470.90
7D
1.3%
1Y
-40.4%